生物活性 | |||
---|---|---|---|
描述 | CCG-100602 is a specific inhibitor of MRTF-A/SRF signalling. CCG-100602 specifically blocks MRTF-A nuclear localisation, thereby inhibiting the fibrotic transcription factor SRF and blocking the expression of MRTF-A/SRF activated genes[1][2].At concentrations of 3-30 μM, CCG-100602 reduces the number of adherent hASC cells[2].At concentrations of 5-40 μM, CCG-100602 reduced TGF-β1 (5 mg/ml) induced COL1A1, FN1 and ACTA2 transcription in a dose-dependent manner, and also reduced TGF-β1 induced protein expression of ECM and α-SMA[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.09mL 0.42mL 0.21mL |
10.44mL 2.09mL 1.04mL |
20.89mL 4.18mL 2.09mL |
参考文献 |
---|